Literature DB >> 21152933

Structural abnormalities in the cortex of the rTg4510 mouse model of tauopathy: a light and electron microscopy study.

Adam E Ludvigson1, Jennifer I Luebke, Jada Lewis, Alan Peters.   

Abstract

rTg4510 transgenic (TG) mice overexpress mutant (P301L) human tau protein. We have compared the dorsal premotor cortex of TG mice versus non-transgenic (NT) mice at 4, 9, and 13 months of age, using light (LM) and electron microscopy (EM). LM assessment shows that cortical thickness in TG mice is reduced by almost 50% from 4 to 13 months of age, while at the same time layer I thickness is reduced by 80%, with most of the cortical thinning occurring between 4 and 9 months. In TG mice, spherical, empty vacuoles, up to 60 μm in diameter, become increasingly abundant with age and by 9 months, pyramidal and non-pyramidal neurons with large intracellular tangles of tau protein are common throughout the cortex. These tangles occur in the perikarya; we have not observed them entering into cellular processes, nor have we observed ghost tangles in the intercellular matrix. In TG mice, nerve fiber pathology is widespread by 13 months, and split myelin sheaths, ballooned sheaths, and swollen axons containing mitochondrial aggregations are all common. Astrocytes become increasingly filled with glial filaments as TG mice age, and microglial cells almost always contain phagocytic inclusions. However, no glial cells are seen to contain tau in their cytoplasm. These observations add to the base of knowledge available on this commonly employed model of tauopathy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21152933      PMCID: PMC3748379          DOI: 10.1007/s00429-010-0295-4

Source DB:  PubMed          Journal:  Brain Struct Funct        ISSN: 1863-2653            Impact factor:   3.270


  38 in total

1.  Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein.

Authors:  J Lewis; E McGowan; J Rockwood; H Melrose; P Nacharaju; M Van Slegtenhorst; K Gwinn-Hardy; M Paul Murphy; M Baker; X Yu; K Duff; J Hardy; A Corral; W L Lin; S H Yen; D W Dickson; P Davies; M Hutton
Journal:  Nat Genet       Date:  2000-08       Impact factor: 38.330

2.  A protein factor essential for microtubule assembly.

Authors:  M D Weingarten; A H Lockwood; S Y Hwo; M W Kirschner
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

3.  Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein.

Authors:  A Probst; J Götz; K H Wiederhold; M Tolnay; C Mistl; A L Jaton; M Hong; T Ishihara; V M Lee; J Q Trojanowski; R Jakes; R A Crowther; M G Spillantini; K Bürki; M Goedert
Journal:  Acta Neuropathol       Date:  2000-05       Impact factor: 17.088

4.  Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

Authors:  J Lewis; D W Dickson; W L Lin; L Chisholm; A Corral; G Jones; S H Yen; N Sahara; L Skipper; D Yager; C Eckman; J Hardy; M Hutton; E McGowan
Journal:  Science       Date:  2001-08-24       Impact factor: 47.728

5.  Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration.

Authors:  Makoto Higuchi; Takeshi Ishihara; Bin Zhang; Ming Hong; Athena Andreadis; John Trojanowski; Virginia M-Y Lee
Journal:  Neuron       Date:  2002-08-01       Impact factor: 17.173

6.  Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease.

Authors:  T Chris Gamblin; Feng Chen; Angara Zambrano; Aida Abraha; Sarita Lagalwar; Angela L Guillozet; Meiling Lu; Yifan Fu; Francisco Garcia-Sierra; Nichole LaPointe; Richard Miller; Robert W Berry; Lester I Binder; Vincent L Cryns
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-29       Impact factor: 11.205

7.  Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology.

Authors:  Robert A Rissman; Wayne W Poon; Mathew Blurton-Jones; Salvatore Oddo; Reidun Torp; Michael P Vitek; Frank M LaFerla; Troy T Rohn; Carl W Cotman
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

8.  Ultrastructural neuronal pathology in transgenic mice expressing mutant (P301L) human tau.

Authors:  Wen-Lang Lin; Jada Lewis; Shu-Hui Yen; Michael Hutton; Dennis W Dickson
Journal:  J Neurocytol       Date:  2003-11

9.  Filamentous tau in oligodendrocytes and astrocytes of transgenic mice expressing the human tau isoform with the P301L mutation.

Authors:  Wen-Lang Lin; Jada Lewis; Shu-Hui Yen; Michael Hutton; Dennis W Dickson
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

Review 10.  Transgenic mouse models of Alzheimer's disease: how useful have they been for therapeutic development?

Authors:  Karen Duff; Faraha Suleman
Journal:  Brief Funct Genomic Proteomic       Date:  2004-04
View more
  16 in total

Review 1.  Are tangles as toxic as they look?

Authors:  Tara L Spires-Jones; Katherine J Kopeikina; Robert M Koffie; Alix de Calignon; Bradley T Hyman
Journal:  J Mol Neurosci       Date:  2011-06-03       Impact factor: 3.444

2.  Dendritic degeneration, neurovascular defects, and inflammation precede neuronal loss in a mouse model for tau-mediated neurodegeneration.

Authors:  Tomasz Jaworski; Benoit Lechat; David Demedts; Lies Gielis; Herman Devijver; Peter Borghgraef; Hans Duimel; Fons Verheyen; Sebastian Kügler; Fred Van Leuven
Journal:  Am J Pathol       Date:  2011-08-10       Impact factor: 4.307

3.  Tau accumulation causes mitochondrial distribution deficits in neurons in a mouse model of tauopathy and in human Alzheimer's disease brain.

Authors:  Katherine J Kopeikina; George A Carlson; Rose Pitstick; Adam E Ludvigson; Alan Peters; Jennifer I Luebke; Robert M Koffie; Matthew P Frosch; Bradley T Hyman; Tara L Spires-Jones
Journal:  Am J Pathol       Date:  2011-08-18       Impact factor: 4.307

4.  Area-Specific Features of Pyramidal Neurons-a Comparative Study in Mouse and Rhesus Monkey.

Authors:  Joshua P Gilman; Maria Medalla; Jennifer I Luebke
Journal:  Cereb Cortex       Date:  2017-03-01       Impact factor: 5.357

5.  Comparative ultrastructural features of excitatory synapses in the visual and frontal cortices of the adult mouse and monkey.

Authors:  Alexander Hsu; Jennifer I Luebke; Maria Medalla
Journal:  J Comp Neurol       Date:  2017-03-26       Impact factor: 3.215

Review 6.  The intersection of amyloid β and tau in glutamatergic synaptic dysfunction and collapse in Alzheimer's disease.

Authors:  Johanna L Crimins; Amy Pooler; Manuela Polydoro; Jennifer I Luebke; Tara L Spires-Jones
Journal:  Ageing Res Rev       Date:  2013-03-22       Impact factor: 10.895

7.  miR-142-3p regulates cortical oligodendrocyte gene co-expression networks associated with tauopathy.

Authors:  Jason D Hinman; Kathie J Ngo; Deborah Kim; Cidi Chen; Carmela R Abraham; Mohsen Ghanbari; M Arfan Ikram; Steven A Kushner; Riki Kawaguchi; Giovanni Coppola; Kerstin Goth; Saverio Bellusci; Israel Hernandez; Kenneth S Kosik; Brent L Fogel
Journal:  Hum Mol Genet       Date:  2021-03-25       Impact factor: 6.150

8.  Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy.

Authors:  Laura J Blair; Haley D Frauen; Bo Zhang; Bryce A Nordhues; Sara Bijan; Yen-Chi Lin; Frank Zamudio; Lidice D Hernandez; Jonathan J Sabbagh; Maj-Linda B Selenica; Chad A Dickey
Journal:  Acta Neuropathol Commun       Date:  2015-01-31       Impact factor: 7.801

9.  Tau deposition drives neuropathological, inflammatory and behavioral abnormalities independently of neuronal loss in a novel mouse model.

Authors:  Casey Cook; Silvia S Kang; Yari Carlomagno; Wen-Lang Lin; Mei Yue; Aishe Kurti; Mitsuru Shinohara; Karen Jansen-West; Emilie Perkerson; Monica Castanedes-Casey; Linda Rousseau; Virginia Phillips; Guojun Bu; Dennis W Dickson; Leonard Petrucelli; John D Fryer
Journal:  Hum Mol Genet       Date:  2015-08-13       Impact factor: 6.150

10.  Early structural and functional defects in synapses and myelinated axons in stratum lacunosum moleculare in two preclinical models for tauopathy.

Authors:  Hervé Maurin; Seon-Ah Chong; Igor Kraev; Heather Davies; Anna Kremer; Claire Marie Seymour; Benoit Lechat; Tomasz Jaworski; Peter Borghgraef; Herman Devijver; Geert Callewaert; Michael G Stewart; Fred Van Leuven
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.